1. Home
  2. MGF vs STRO Comparison

MGF vs STRO Comparison

Compare MGF & STRO Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo MFS Government Markets Income Trust

MGF

MFS Government Markets Income Trust

HOLD

Current Price

$2.99

Market Cap

99.1M

Sector

Finance

ML Signal

HOLD

Logo Sutro Biopharma Inc.

STRO

Sutro Biopharma Inc.

HOLD

Current Price

$20.43

Market Cap

85.0M

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
MGF
STRO
Founded
1987
2003
Country
United States
United States
Employees
N/A
N/A
Industry
Trusts Except Educational Religious and Charitable
Biotechnology: Biological Products (No Diagnostic Substances)
Sector
Finance
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
99.1M
85.0M
IPO Year
N/A
N/A

Fundamental Metrics

Financial Performance
Metric
MGF
STRO
Price
$2.99
$20.43
Analyst Decision
Hold
Analyst Count
0
8
Target Price
N/A
$18.88
AVG Volume (30 Days)
67.9K
116.6K
Earning Date
01-01-0001
01-01-0001
Dividend Yield
7.64%
N/A
EPS Growth
N/A
N/A
EPS
N/A
N/A
Revenue
N/A
N/A
Revenue This Year
N/A
$63.08
Revenue Next Year
N/A
N/A
P/E Ratio
N/A
N/A
Revenue Growth
N/A
N/A
52 Week Low
$2.93
$0.52
52 Week High
$3.17
$20.59

Technical Indicators

Market Signals
Indicator
MGF
STRO
Relative Strength Index (RSI) 42.46 73.10
Support Level N/A $0.76
Resistance Level $3.12 N/A
Average True Range (ATR) 0.03 1.70
MACD -0.00 0.27
Stochastic Oscillator 46.15 94.68

Price Performance

Historical Comparison
MGF
STRO

About MGF MFS Government Markets Income Trust

MFS Government Markets Income Trust is a United States-based diversified, closed-end management investment company. Its investment objective is to seek high current income. The fund invests a majority of the net assets, including borrowings for investment purposes, in U.S. and foreign government securities. The company invest various sectors like U.S. Treasury Securities, Mortgage-Backed Securities, Investment Grade Corporates, Municipal Bonds, Non-U.S. Government Bonds, etc, out of which maximum revenue is gained from U.S. Treasury Securities.

About STRO Sutro Biopharma Inc.

Sutro Biopharma Inc is a clinical-stage drug discovery, development, and manufacturing company. It is mainly engaged in the development of biopharmaceutical products. The company manufactures next-generation protein therapeutics for cancer and autoimmune disorders through its proprietary integrated cell-free protein synthesis platform, XpressCF. Products offered by the company include STRO-001 for patients with multiple myeloma and non-Hodgkin lymphoma and STRO-002 for the treatment of ovarian and endometrial cancers. The company also pipeline contains STRO-004, STRO-006, STRO-00X, STRO-00Y, STRO-003, VAX24, VAX31, and Others.

Share on Social Networks: